Doxy-Caps en es it fr

Doxy-Caps Brand names, Doxy-Caps Analogs

Doxy-Caps Brand Names Mixture

  • No information avaliable

Doxy-Caps Chemical_Formula

C22H24N2O8

Doxy-Caps RX_link

http://www.rxlist.com/cgi/generic/doxycyc.htm

Doxy-Caps fda sheet

Doxy-Caps FDA

Doxy-Caps msds (material safety sheet)

Doxy-Caps MSDS

Doxy-Caps Synthesis Reference

C. R. Stephens et al.; J. Am. Chem. Soc. 80; 5324 (1958)

Doxy-Caps Molecular Weight

444.435 g/mol

Doxy-Caps Melting Point

201 oC

Doxy-Caps H2O Solubility

630 mg/L

Doxy-Caps State

Solid

Doxy-Caps LogP

-1.219

Doxy-Caps Dosage Forms

Tablet; Capsule; Gel; Liquid; Powder; Powder for solution

Doxy-Caps Indication

For the treatment of the following infections:Rocky mountain spotted fever, typhus fever and the typhus group, Q fever, rickettsialpox, and tick fevers caused by Rickettsiae, Chancroid caused by Haemophilus ducreyi, Uncomplicated gonorrhea caused by Neisseria gonorrhoeae, Respiratory tract infections caused by Mycoplasma pneumoniae or Streptococcus pneumoniae. Lymphogranuloma ve

Doxy-Caps Pharmacology

Doxycycline, a long-acting tetracycline derived from oxytetracycline, is used to inhibit bacterial protein synthesis and treat non-gonococcal urethritis and cervicitis, exacerbations of bronchitis in patients with COPD, and adult periodontitis.

Doxy-Caps Absorption

completely absorbed after oral administration

Doxy-Caps side effects and Toxicity

anorexia, nausea, diarrhoea, glossitis, dysphagia, enterocolitis and inflammatory lesions (with monilial overgrowth) in the anogenital region. skin reactions such as maculopapular and erythematous rashes, exfoliative dermatitis, photosensitivity, hypersensitivity reactions such as urticaria, angioneurotic oedema, anaphylaxis, anaphyl-actoid purpura, pericarditis, and exacerbation of systemic lupus erythematosus, benign intracranial hypertension in adults disappearing on discontinuation of the medicine, haematologic abnormalities such as haemolytic anaemia, thrombocytopenia, neutropenia, and eosinophilia. LD50=262 mg/kg(i.p. in rat)

Doxy-Caps Patient Information

Doxy-Caps Organisms Affected

Enteric bacteria and other eubacteria